Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 11, 2020

SELL
$37.79 - $51.33 $554,757 - $753,524
-14,680 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$42.46 - $50.46 $253,656 - $301,448
-5,974 Reduced 28.92%
14,680 $732,000
Q4 2018

Feb 08, 2019

BUY
$36.86 - $41.49 $761,306 - $856,934
20,654 New
20,654 $784,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $209B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Dc Investments Management, LLC Portfolio

Follow Dc Investments Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dc Investments Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dc Investments Management, LLC with notifications on news.